NCT03479528 is a clinical trial in Dyspepsia, sponsored by Second Affiliated Hospital of Xi'an Jiaotong University.

Who is sponsoring NCT03479528?

NCT03479528 is sponsored by Second Affiliated Hospital of Xi'an Jiaotong University.

Is NCT03479528 still recruiting?

NCT03479528 is currently status unknown. Last updated 14 January 2019.

Last reviewed 2019-01-14 · How we verify

NCT03479528

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Predictive Value of Alarm Symptoms in Patients With Dyspepsia Based on Roman IV

Status unknown Last updated 14 January 2019

What this trial tests

trial in Dyspepsia in 800 participants. Status unknown.

Timeline

1 March 2018

Primary endpoint
31 January 2019

31 January 2019

Quick facts

Lead sponsor	Second Affiliated Hospital of Xi'an Jiaotong University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	800
Start date	1 March 2018
Primary completion	31 January 2019
Estimated completion	31 January 2019
Sites	1 location across China

Conditions studied

Dyspepsia — all drugs for Dyspepsia →

Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Who can join

18 and older, any sex, with Dyspepsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice.Clinical diagnosis is notoriously unreliable in diagnosing the underlying cause of dyspepsia,but a number of alarm features have been suggested as indicating patients at higher risk for serious disease. The predictive value of alarm symptoms still require more researches. Rome IV introduced more precisely define the minimal thresholds for frequency and severity of each individual symptom, primarily for scientific purposes,but data still need to be collected to define thresholds based on the frequency and/or severity of symptoms that impair quality of life.A cross-sectional study was conducted to assess the predictive value of alarm symptoms in patients with dyspepsia based on Roman IV.Through endoscopy results to determine whether dyspepsia is organic or functional, benign or malignant, through contacts with the basic data, to determine the alarm symptoms

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Rome III, Rome IV, and Potential Asia Symptom Criteria for Functional Dyspepsia Do Not Reliably Distinguish Functional From Organic Disease.
Wei Z, Yang Q, Yang Q, Yang J, et al · · 2020 · cited 13× · PMID 33512804 · DOI 10.14309/ctg.0000000000000278
Predictive value of alarm symptoms in patients with Rome IV dyspepsia: A cross-sectional study.
Wei ZC, Yang Q, Yang Q, Yang J, et al · · 2020 · cited 3× · PMID 32874062 · DOI 10.3748/wjg.v26.i30.4523

Verify or expand the search:

Other recruiting trials for Dyspepsia

Currently open trials in the same condition.

NCT06941545 — High Resolution Gastric Mapping and Gastroduodenal Manometry · NA · recruiting
NCT07261228 — The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper · recruiting
NCT06755671 — A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms · recruiting
NCT06422052 — Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspep · recruiting
NCT05810168 — Traditional Dietary Advice Versus Low FODMAP Diet in Postprandial Functional Dyspepsia · NA · recruiting

Other Second Affiliated Hospital of Xi'an Jiaotong University trials

Trials by the same sponsor.

NCT07160361 — Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB · Phase 4 · not yet recruiting
NCT07346456 — Comparison of IOL Formulas in Eyes With PCE≥15µm · completed
NCT06998589 — Comparison of the Efficacy and Safety of Delicate Pulsed Light and Q-Switched 1064 nm Nd:YAG Laser in the Treatment of P · NA · completed
NCT07305675 — Effectiveness of a rhGM-CSF-containing Gel on Promoting Recovery After 1927-nm Fractional Thulium Fiber Laser Treatment · NA · completed
NCT06791005 — A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer. · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03479528 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital of Xi'an Jiaotong University
Last refreshed: 14 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03479528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing